Evidence map›Paper›PMID 34510542›Full record

ReviewJournal of clinical apheresis2021

The report from ASFA COVID-19 taskforce: Considerations and prioritization on apheresis procedures during the SARS-CoV-2 coronavirus disease (COVID-19) pandemic.

Chisa Yamada, Jan C Hofmann, Volker Witt, Gaurav K Gupta, Jeffrey L Winters, ASFA COVID-19 Taskforce

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of clinical apheresis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 2 countries.

Chisa YamadaDivision of Transfusion Medicine, Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA.ORCID https://orcid.org/0000-0002-1968-2385
Jan C HofmannDivision of Transfusion Medicine, Department of Laboratory Medicine, University of California San Francisco School of Medicine, San Francisco, California, USA.
Volker WittDivision of Pediatric Apheresis, Department of Pediatrics, St. Anna Kinderspital, Medical University of Vienna, Vienna, Austria.
Gaurav K GuptaTransfusion Medicine and Cell Therapy, Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.ORCID https://orcid.org/0000-0002-2951-0034
Jeffrey L WintersDivision of Transfusion Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
ASFA COVID-19 Taskforce
Analytical Services · USMayo Clinic · USMemorial Sloan Kettering Cancer Center · USSt Anna Children's Hospital · ATUniversity of California, San Francisco · USUniversity of Michigan · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Since vaccination for SARS-CoV-2 coronavirus started, the trajectory of patient numbers infected with the virus has improved once; however, variants of SARS-CoV-2 have emerged and more people have been infected; therefore, pandemic status is still far from resolution. Government and social efforts to prevent coronavirus infection continue in most states in the US and globally even after the Centers for Disease Control and Prevention declared some restriction relief for fully vaccinated people in March 2021. Healthcare institutions and various professional organizations have developed guidelines or policies to prevent the spread of these coronaviruses in the setting of apheresis. In this report, the issues that apheresis services may encounter under the current COVID-19 (SARS-CoV-2 coronavirus disease) pandemic will be discussed with potential strategies that can be adapted for efficient and optimum use of apheresis resources.

Indexed as

Blood Component RemovalPandemicsCOVID-19HumansPractice Guidelines as TopicSARS-CoV-2Societies, MedicalUnited Statesapheresis in COVID-19 pandemicASFA COVID-19 TaskforceSARS-CoV-2

Identifiers

PMID34510542
PMCPMC8646674
OpenAlexW3201376681

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.